Stephen David Prior

ANTX

Stephen David Prior serves as officer: Chief Strategy Officer at AN2 Therapeutics, Inc. (ANTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$16.6K

Net Position

Net Seller

$16.6K

Companies Traded

ANTX

Active Period

Jan 2025 – Jan 2026

4 total trades

Most Recent

Sell ANTX

Jan 7, 2026 · $6.5K

Stephen David Prior's Insider Trading at AN2 Therapeutics, Inc. (ANTX)

Buys

0 · $0.00

Sells

4 · $16.6K

Total Shares Bought

Total Shares Sold

15,718

ANTX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Jan 7, 2026	Sell	6,462	$1.01	$6.5K	61,944
Jan 5, 2026	Sell	6,462	$1.01	$6.5K	0
Nov 4, 2025	Sell	765	$1.14	$872.10	0
Jan 3, 2025	Sell	2,029	$1.34	$2.7K	0

Related Insiders

Sarah Joanne Williams

officer: Principal Accounting Officer

ANTXSell · Mar 5, 2026

Lucy Day

officer: Chief Financial Officer

ANTXSell · Jan 7, 2026

Sanjay Chanda

officer: Chief Development Officer

ANTXSell · Jan 7, 2026

Joshua M Eizen

See Remarks

ANTXSell · Jan 7, 2026

Braden Michael Leonard

10% Owner

ANTXSell · Jun 12, 2025

Eric Easom

Chief Executive Officer

ANTXBuy · Jun 2, 2025

Margaret M FitzPatrick

Director

ANTXBuy · May 28, 2025

Explore More Insider Trading Data

ANTX Insider Trading Activity

View all insider trades at AN2 Therapeutics, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity